Valacyclovir 500 mg once daily is approximately equivalent to acyclovir 200 mg three times daily in an adult with normal renal function.
For practical dose conversion: acyclovir 200 mg given 3-5 times daily can be replaced with valacyclovir 500 mg once or twice daily, depending on the indication.
Pharmacokinetic Basis for Conversion
Valacyclovir is the L-valine ester prodrug of acyclovir that achieves 3-5 times higher acyclovir bioavailability compared to oral acyclovir 1, 2, 3. After oral administration, valacyclovir is rapidly converted to acyclovir through first-pass intestinal and hepatic metabolism 1.
The absolute bioavailability of acyclovir is:
This means valacyclovir delivers approximately twice the systemic acyclovir exposure per milligram compared to oral acyclovir 2.
Specific Dose Equivalencies by Indication
For Genital Herpes Treatment
- Acyclovir 200 mg 5 times daily = Valacyclovir 1000 mg twice daily 1, 4, 5
- Clinical trials demonstrated equivalent efficacy for lesion healing (median 9 days for both), cessation of pain (5 days), and viral shedding (3 days) 1, 5
For Genital Herpes Suppression
- Acyclovir 400 mg twice daily = Valacyclovir 500-1000 mg once daily 1
- At 12 months, both regimens kept 34% of patients recurrence-free versus 4% with placebo 1
For Herpes Labialis (Cold Sores)
- Acyclovir 200 mg 5 times daily can be replaced with Valacyclovir 2000 mg twice daily for 1 day 1
Mathematical Conversion for 200 mg Acyclovir
Given the bioavailability difference:
- Acyclovir 200 mg delivers approximately 53 mg of systemic acyclovir (26.7% bioavailability)
- To match this with valacyclovir: 53 mg ÷ 0.545 = 97 mg of valacyclovir needed
- However, valacyclovir contains only 69.4% acyclovir by weight 2
- Practical equivalent: Valacyclovir 150-200 mg would theoretically match acyclovir 200 mg
In clinical practice, the smallest valacyclovir dose is 500 mg, which exceeds the exposure from acyclovir 200 mg by 2-3 fold. This is why valacyclovir dosing frequency is reduced (once or twice daily vs. 3-5 times daily for acyclovir).
Renal Dosing Considerations
Both drugs require adjustment in renal impairment 6, 7, 6:
For CrCl <30 mL/min:
- Acyclovir 200 mg: reduce to 200 mg every 12 hours 6
- Valacyclovir 500 mg: reduce to 500 mg every 24-48 hours 6, 7, 6
For hemodialysis:
- Acyclovir: 200 mg every 12 hours, dose after dialysis 6
- Valacyclovir: 500 mg after each dialysis 6, 7
Clinical Caveats
- No direct 1:1 conversion exists because valacyclovir's superior bioavailability allows less frequent dosing rather than equivalent single-dose substitution
- The improved bioavailability translates to convenience (fewer daily doses) rather than lower total daily drug amounts 4, 8, 3
- Compliance is significantly better with valacyclovir's twice-daily regimen versus acyclovir's 5-times-daily schedule 4, 8
- High-dose valacyclovir (≥3 g/day) carries risk of thrombocytopenia and neurotoxicity, particularly in elderly patients or those with renal impairment 9, 10